Stay updated with breaking news from Eric Venker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) rose 3.3% on Wednesday . The company traded as high as $10.10 and last traded at $10.08. Approximately 380,525 shares were traded during trading, a decline of 89% from the average daily volume of 3,416,878 shares. The stock had previously closed at $9.76. Analyst Ratings Changes Several analysts […]
Cantor Fitzgerald restated their overweight rating on shares of Roivant Sciences (NASDAQ:ROIV – Get Rating) in a research report sent to investors on Tuesday morning, PriceTargets.com reports. A number of other equities analysts also recently weighed in on ROIV. JPMorgan Chase & Co. boosted their price target on shares of Roivant Sciences from $12.00 to […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) COO Eric Venker sold 299,384 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $9.91, for a total transaction of $2,966,895.44. Following the sale, the chief operating officer now owns 660,097 shares of the […]
Bank of America initiated coverage on shares of Roivant Sciences (NASDAQ:ROIV – Get Rating) in a research note published on Thursday, The Fly reports. The brokerage issued a neutral rating and a $10.50 price target on the stock. Several other equities research analysts have also recently weighed in on ROIV. HC Wainwright upped their price […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) COO Eric Venker sold 299,384 shares of the stock in a transaction on Friday, June 9th. The stock was sold at an average price of $9.91, for a total transaction of $2,966,895.44. Following the sale, the chief operating officer now directly owns 660,097 shares of the company’s stock, […]